Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination
- 31 March 2004
- journal article
- research article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 148 (1-2), 200-205
- https://doi.org/10.1016/j.jneuroim.2003.11.017
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 19 references indexed in Scilit:
- Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: Clinical featuresOphthalmology, 2001
- Anti-GQ1b IgG antibody syndrome: clinical and immunological rangeJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Inter‐laboratory validation of an ELISA for the determination of serum anti‐ganglioside antibodiesEuropean Journal of Neurology, 1999
- Close association of Guillain–Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1αJournal of Neuroimmunology, 1997
- The clinical correlates of high‐titer IgG anti‐GM1 antibodiesAnnals of Neurology, 1994
- Serum anti‐GQ 1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barré syndromeNeurology, 1993
- Frequent presence of anti‐G Q1b antibody in Fisher's syndromeNeurology, 1993
- Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndromeAnnals of Neurology, 1992
- Assessment of current diagnostic criteria for Guillain-Barr syndromeAnnals of Neurology, 1990